Press Releases

Date	Title	Company
02-Dec-2022	Aromatherapy Market to Exhibit Opulent CAGR of 8.1% From 2022 to 2032 Attributing to its Increasingly Popular Among Wellness Professionals	MARKITWIRED
02-Dec-2022	Sphingolipids Market Growth Accelerating with the Increasing Demand for Sphingolipids from Various End-Use Industries Such as Skin Care, Hair Care: Future Market Insights	MARKITWIRED
02-Dec-2022	The global surface plasmon resonance market is estimated to be valued at US$ 910.4 Mn in 2022 and is expected to reach US$ 1807.7 Mn by 2032	MARKITWIRED
02-Dec-2022	Rising Pediatric and Geriatric Patient Preference for Softgel Capsules is expected to Drive Market Growth: Get Insights FMI	MARKITWIRED
02-Dec-2022	Proteomics Market size to reach around US$ 109.4 Billion by the end of 2032 \| CAGR of 13.5% \| Exclusive Report by FMI	MARKITWIRED
02-Dec-2022	Synthetic Biology Market will reach a value of US$ 138.8 Bn by 2032 at a CAGR of 24.3% \| Get Insights FMI	MARKITWIRED
02-Dec-2022	Teeth Whitening Market value is estimated to reach US$ 6.6 Bn in 2022 and is projected to reach US$ 10.7 Bn by the year 2032 end – FMI	MARKITWIRED
02-Dec-2022	Rise in Demand for Minimal Invasive Procedures, and Rapidly Aging Global Population are Uplifting the Arthroscopy Visualization Systems Market: Future Market Insights	MARKITWIRED
02-Dec-2022	Synthetic Biology Market will reach a value of US$ 138.8 Bn by 2032 at a CAGR of 24.3% \| Future Market Insights	MARKITWIRED
02-Dec-2022	Molecular Diagnostics Market to grow at a rate of 18% by 2022-2032 \| Get Customized Reports	MARKITWIRED
02-Dec-2022	Regenerative Artificial Skin Market Expected to Witness a CAGR of 9.9% through year 2022-2032	MARKITWIRED
02-Dec-2022	Quadriplegia Treatment Market size worth US$ 2,324.4 Mn by 2032 \| Get Insights FMI	MARKITWIRED
02-Dec-2022	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of DLocal Limited (DLO) on Behalf of Investors	Businesswire
02-Dec-2022	MERGE’s Dr. Kirsten Ambegaokar Named To MM+M’s 40 Under 40 List Chicago	Businesswire
02-Dec-2022	Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer	Businesswire
02-Dec-2022	Otsuka Pharmaceutical & Lundbeck Present Positive Data From Multiple Phase 3 Studies Showing Brexpiprazole Significantly Improved Symptoms of Agitation in Patients With Alzheimer’s Dementia at the 2022 Clinical Trials for Alzheimer’s Disease Congress	Businesswire
02-Dec-2022	Miller Law LLC and Safirstein Law LLC Announce Proposed Settlements in the Namenda Indirect Purchaser Antitrust Litigation	Businesswire
02-Dec-2022	Rocket Pharmaceuticals Completes Acquisition of Renovacor	Businesswire
01-Dec-2022	Everest Clinical Research, an Arlington Capital Partners Portfolio Company, Announces the Acquisition of Brightech International	Businesswire
01-Dec-2022	NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	Businesswire